PI
EW icon

PEAK6 Investments’s Edwards Lifesciences EW Stock Holding History

PEAK6 Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.36M Sell
35,800
-47,900
-57% -$3.48M 0.01% 1402
2024
Q2 		$7.73M Sell
83,700
-56,800
-40% -$5.03M 0.02% 612
2024
Q1 		$13.4M Buy
140,500
+62,800
+81% +$5.28M 0.04% 404
2023
Q4 		$5.92M Buy
77,700
+68,200
+718% +$4.75M 0.02% 723
2023
Q3 		$658K Sell
9,500
-19,500
-67% -$1.57M ﹤0.01% 2160
2023
Q2 		$2.74M Sell
29,000
-28,800
-50% -$2.5M 0.01% 990
2023
Q1 		$4.78M Sell
57,800
-20,500
-26% -$1.61M 0.02% 726
2022
Q4 		$5.84M Sell
78,300
-3,400
-4% -$262K 0.03% 632
2022
Q3 		$6.75M Sell
81,700
-24,500
-23% -$2.36M 0.03% 645
2022
Q2 		$10.1M Buy
106,200
+68,000
+178% +$7.04M 0.02% 853
2022
Q1 		$4.5M Sell
38,200
-45,900
-55% -$5.15M 0.01% 1190
2021
Q4 		$10.9M Buy
84,100
+80,200
+2,056% +$9.35M 0.02% 675
2021
Q3 		$442K Sell
3,900
-14,400
-79% -$1.64M ﹤0.01% 3360
2021
Q2 		$1.9M Sell
18,300
-1,300
-7% -$123K ﹤0.01% 1953
2021
Q1 		$1.64M Sell
19,600
-332,700
-94% -$28.1M ﹤0.01% 2083
2020
Q4 		$32.1M Sell
352,300
-242,600
-41% -$20.1M 0.07% 258
2020
Q3 		$47.5M Buy
594,900
+429,900
+261% +$33.5M 0.12% 153
2020
Q2 		$11.4M Buy
165,000
+146,400
+787% +$10.4M 0.04% 436
2020
Q1 		$1.17M Sell
18,600
-17,400
-48% -$1.25M 0.01% 1423
2019
Q4 		$2.8M Sell
36,000
-21,600
-38% -$1.69M 0.01% 897
2019
Q3 		$4.22M Buy
57,600
+34,200
+146% +$2.4M 0.03% 775
2019
Q2 		$1.44M Sell
23,400
-43,200
-65% -$2.61M 0.01% 1531
2019
Q1 		$4.25M Sell
66,600
-30,300
-31% -$1.73M 0.02% 797
2018
Q4 		$4.95M Sell
96,900
-147,000
-60% -$7.44M 0.03% 644
2018
Q3 		$14.2M Buy
+243,900
New +$11.9M 0.06% 331

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

PEAK6 Investments's EW Position: Q3 2024 in Review

PEAK6 Investments increased its Edwards Lifesciences (EW) stake by 504% in Q3 2024, buying an estimated $2.93M and bringing the position to 48,322 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #1202.

PEAK6 Investments first reported a position in EW in Q4 2018 and has held it in 13 quarters since. The position peaked at $5.01M in Q1 2022. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • PEAK6 Investments held 48,322 shares of Edwards Lifesciences worth $3.19M as of Q3 2024.
  • PEAK6 Investments bought 40,325 Edwards Lifesciences shares in Q3 2024, an estimated $2.93M.
  • Edwards Lifesciences made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1202 holding.
  • PEAK6 Investments first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 13 quarters since.
  • PEAK6 Investments's Edwards Lifesciences position peaked at $5.01M in Q1 2022.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.